New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
08:20 EDTROSGRosetta Genomics to receive U.S. patent for cancer origin assay
Rosetta Genomics announced that the company received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering the method of use of a core element of Rosetta Genomics' microRNA technology in the identification of the tumor of origin in cancer of unknown or uncertain primary and metastatic cancer. The issued claims for U.S. Patent Application No. 13/167,489 is entitled "Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples."
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
08:32 EDTROSGRosetta Genomics announces data published in Leukemia Research
Subscribe for More Information
April 17, 2015
10:00 EDTROSGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CECO Environmental (CECE) upgraded on several positive catalysts at Roth Capital... EMC (EMC) upgraded to Outperform from Market Perform at Bernstein... Fleetmatics (FLTX) upgraded to Overweight from Neutral at Piper Jaffray... NorthStar Asset Management (NSAM) upgraded to Buy from Hold at MLV & Co.... Penn National (PENN) upgraded to Overweight from Neutral at JPMorgan... Rosetta Genomics (ROSG) upgraded to Buy from Hold at Cantor... Ulta Salon (ULTA) upgraded to Buy from Neutral at Nomura... Xcel Energy (XEL) upgraded to Buy from Hold at Argus.
09:14 EDTROSGOn The Fly: Pre-market Movers
Subscribe for More Information
06:33 EDTROSGRosetta Genomics upgraded to Buy from Hold at Cantor
Subscribe for More Information
April 16, 2015
11:16 EDTROSGRosetta Genomics receives patent allowance for cancer of origin diagnostic assay
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use